Literature DB >> 18496154

Gentamicin increases nitric oxide production and induces hearing loss in guinea pigs.

Ulf-Rüdiger Heinrich1, Kai Helling, Marco Sifferath, Jürgen Brieger, Huige Li, Irene Schmidtmann, Wolf J Mann.   

Abstract

OBJECTIVES/HYPOTHESIS: Gentamicin application is an important therapeutic option for Ménière's disease. However, even if given at intervals, a destruction of the cochlea was often observed in various animal models together with an increased content of nitric oxide (NO) and reactive oxygen species. The present study was undertaken to identify the correlation between hearing threshold alteration and the NO production in the lateral wall and organ of Corti of the guinea pig in response to gentamicin application. STUDY
DESIGN: Prospective animal study in guinea pigs.
METHODS: A single dose of gentamicin (10 mg/kg body weight) was injected intratympanally into male guinea pigs and the auditory brainstem responses were recorded before treatment and 1, 2, and 7 days after application. The organ of Corti and the lateral wall were removed from the bulla, incubated separately for 6 hours in cell culture medium and the amount of NO production was determined by chemiluminescence.
RESULTS: Gentamicin application resulted in a hearing threshold shift beginning on the second day after gentamicin application. This hearing impairment correlates simultaneously with an increased NO2(-) content--the stable oxidation product of NO--in the lateral wall. In the organ of Corti, a slight increase in NO2(-) production was seen as early as on day 1 after gentamicin injection.
CONCLUSIONS: The correlation between hearing threshold shift and NO production in the cochlea leads to the assumption that increased NO contributes to gentamicin-induced hearing impairment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18496154     DOI: 10.1097/MLG.0b013e3181739bd9

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

Review 1.  [Possible molecular mechanisms of spontaneous remission in sudden idiopathic hearing loss].

Authors:  U-R Heinrich; J Brieger; R H Stauber; W J Mann
Journal:  HNO       Date:  2011-11       Impact factor: 1.284

2.  Aminoglycoside Increases Permeability of Osseous Spiral Laminae of Cochlea by Interrupting MMP-2 and MMP-9 Balance.

Authors:  Dengke Li; Jianhe Sun; Lidong Zhao; Weiwei Guo; Wei Sun; Shiming Yang
Journal:  Neurotox Res       Date:  2016-12-22       Impact factor: 3.911

3.  Efficacy of three drugs for protecting against gentamicin-induced hair cell and hearing losses.

Authors:  E Bas; T R Van De Water; C Gupta; J Dinh; L Vu; F Martínez-Soriano; J M Láinez; J Marco
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

4.  Generation of highly-reactive oxygen species is closely related to hair cell damage in rat organ of Corti treated with gentamicin.

Authors:  Y H Choung; A Taura; K Pak; S J Choi; M Masuda; A F Ryan
Journal:  Neuroscience       Date:  2009-03-24       Impact factor: 3.590

5.  Assessment of nutrient supplement to reduce gentamicin-induced ototoxicity.

Authors:  C G Le Prell; C Ojano-Dirain; E W Rudnick; M A Nelson; S J DeRemer; D M Prieskorn; J M Miller
Journal:  J Assoc Res Otolaryngol       Date:  2014-03-04

6.  (-)-Epigallocatechin-3-gallate protects against NO-induced ototoxicity through the regulation of caspase- 1, caspase-3, and NF-κB activation.

Authors:  Su-Jin Kim; Jeong-Han Lee; Beom-Su Kim; Hong-Seob So; Raekil Park; Noh-Yil Myung; Jae-Young Um; Seung-Heon Hong
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

7.  Fenofibrate exerts protective effects against gentamicin-induced toxicity in cochlear hair cells by activating antioxidant enzymes.

Authors:  Channy Park; Hye-Min Ji; Se-Jin Kim; Sung-Hee Kil; Joon No Lee; Seongae Kwak; Seong-Kyu Choe; Raekil Park
Journal:  Int J Mol Med       Date:  2017-03-10       Impact factor: 4.101

8.  Increased Risk of Sensorineural Hearing Loss as a Result of Exposure to Air Pollution.

Authors:  Kuang-Hsi Chang; Stella Chin-Shaw Tsai; Chang-Yin Lee; Ruey-Hwang Chou; Hueng-Chuen Fan; Frank Cheau-Feng Lin; Cheng-Li Lin; Yi-Chao Hsu
Journal:  Int J Environ Res Public Health       Date:  2020-03-17       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.